Literature DB >> 19041722

Recombinant expression of biologically active murine soluble EPCR.

Jacinto López-Sagaseta1, Ramón Montes, José Hermida.   

Abstract

Endothelial cell protein C receptor (EPCR) downregulates the coagulation system and prevents thrombosis by binding to protein C/activated protein C (APC) and factor VII/activated factor VII (VIIa). Recombinant APC and factor VIIa have been shown to be useful in a variety of clinical conditions. Murine models could prove extremely helpful in order to study in vivo actions of these drugs. It is therefore crucial to demonstrate the interaction between these and murine EPCR. We expressed the extracellular region of the murine EPCR in a yeast expression system and obtained a colony of Pichia pastoris that produce high amounts of recombinant extracellular murine EPCR, which we purified by liquid chromatography to homogeneity. The analysis of the interaction of EPCR with APC and factor VIIa was carried out using surface plasmon resonance technology. Murine EPCR binds to APC and factor VIIa with similar affinity than human EPCR. As for human EPCR, the binding is Ca2+ dependent while Mg2+ ions optimize it. In conclusion, we succeeded in establishing a system to produce enough recombinant soluble murine EPCR to perform biochemical studies. Murine EPCR binds to human APC and factor VIIa, which opens up new possibilities for characterizing the in vivo effect of APC and factor VII by using murine models.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041722     DOI: 10.1016/j.pep.2008.11.002

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  4 in total

Review 1.  Endothelial cell protein C receptor: a multiliganded and multifunctional receptor.

Authors:  L Vijaya Mohan Rao; Charles T Esmon; Usha R Pendurthi
Journal:  Blood       Date:  2014-07-21       Impact factor: 22.113

2.  The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors.

Authors:  Jennifer Disse; Helle Heibroch Petersen; Katrine S Larsen; Egon Persson; Naomi Esmon; Charles T Esmon; Luc Teyton; Lars C Petersen; Wolfram Ruf
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

3.  Protective effects of non-anticoagulant activated protein C variant (D36A/L38D/A39V) in a murine model of ischaemic stroke.

Authors:  Anna P Andreou; Maria Efthymiou; Yao Yu; Helena R Watts; Faruq H Noormohamed; Daqing Ma; David A Lane; James T B Crawley
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

4.  Blocking human protein C anticoagulant activity improves clotting defects of hemophilia mice expressing human protein C.

Authors:  Miao Jiang; Fei Yang; Yizhi Jiang; Lu Cheng; Jingjing Han; Jiawei Yi; Guige Zhang; Zhenni Ma; Lijuan Cao; Bin Zuo; Lixia Zhou; Lulu Huang; Siying Niu; Zhisong Xia; Xuefeng Zhou; Xia Bai; Naomi L Esmon; Changgeng Ruan; Lijun Xia; Yue Han; Charles T Esmon; Depei Wu; Jun Xu
Journal:  Blood Adv       Date:  2022-06-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.